Advertisement
Screener

EXAGEN INC. (XGN) EBITDA

EXAGEN INC. (XGN) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$1.12M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$2.81M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$4.38M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$2.5M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2018-09-30 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$1.12M(m)(m)(m)-5.63%$543.00K*$3.99M*$7.72M$1.43M$12.51M$0.00
2026-03-31Reported-$2.81M(m)(m)(m)-16.26%$228.00K-$10.42M$7.10M$1.55M$12.07M$36.00K
2025-12-31Reported-$4.38M(m)(m)(m)-26.31%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$2.5M(m)(m)(m)-14.50%$275.00K*$2.94M*$7.17M$1.73M$11.45M$1.00K
2025-06-30Reported-$2.13M(m)(m)(m)-12.38%$209.00K*-$2.88M*$6.81M$1.48M$11.54M$37.00K
2025-03-31Reported-$2.97M(m)(m)(m)-19.13%$113.00K-$10.67M$6.38M$1.28M$11.20M$0.00
2024-12-31Reported-$2.98M(m)(m)(m)-21.85%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$4.26M(m)(m)(m)-34.08%$147.00K*-$2.18M*$5.53M$1.48M$10.16M$0.00
2024-06-30Reported-$2.19M(m)(m)(m)-14.52%$136.00K*-$2.43M*$6.01M$1.18M$10.46M$0.00
2024-03-31Reported-$2.5M(m)(m)(m)-17.36%$86.00K-$9.04M$5.82M$1.06M$10.54M(m)
2023-12-31Reported-$4.65M(m)(m)(m)-33.76%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$4.47M(m)(m)(m)-33.31%$2.00K*-$2.91M*$5.71M$1.40M$11.38M(m)
2023-06-30Reported-$4.42M(m)(m)(m)-31.23%$324.00K*-$10.15M*$5.84M$1.26M$11.95M(m)
2023-03-31Reported-$7.11M(m)(m)(m)-63.28%$396.00K-$9.75M$5.93M$1.13M$11.88M(m)
2022-12-31Reported-$13.89M(m)(m)(m)-108.21%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$7.42M(m)(m)(m)-50.37%$879.00K*-$6.68M*$6.01M$2.38M$14.15M(m)
2022-06-30Reported-$13.76M(m)(m)(m)-180.96%$1.95M*-$11.15M*$6.08M$2.69M$12.90M(m)
2022-03-31Reported-$9.38M(m)(m)(m)-90.23%$1.09M-$8.57M$5.82M$2.10M$12.15M(m)
2021-12-31Reported-$6.05M(m)(m)(m)-47.71%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$6.2M(m)(m)(m)-50.64%$425.00K*-$5.46M*$5.49M$1.74M$11.53M$0.00
2021-06-30Reported-$5.54M(m)(m)(m)-43.39%$714.00K*-$4.45M*$5.45M$1.89M$11.17M$0.00
2021-03-31Reported-$5.37M(m)(m)(m)-50.69%$167.00K-$4.31M$4.71M$1.40M$10.04M$0.00
2020-12-31Reported-$2.66M(m)(m)(m)-21.01%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$3.69M(m)(m)(m)-34.21%$213.00K*-$2.13M*$4.34M$1.02M$9.20M$0.00
2020-06-30Reported-$3.22M(m)(m)(m)-35.95%$153.00K*-$4.76M*$3.34M$751.00K$8.28M$0.00
2020-03-31Reported-$5.12M(m)(m)(m)-53.43%$84.00K-$3.30M$4.54M$634.00K$9.63M-$118.00K
2019-12-31Reported-$2.76M(m)(m)(m)-27.00%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$2.06M(m)(m)(m)-19.70%$2.00K*-$1.67M*$4.78M$507.00K$7.31M$0.00
2019-06-30Reported-$2.21M(m)(m)(m)-21.10%$12.00K*-$2.17M*$4.99M$590.00K$7.30M$0.00
2019-03-31Reported-$1.67M(m)(m)(m)-18.08%$363.00K-$1.95M$4.44M$513.00K$6.18M$0.00
2018-12-31Reported$49,000.00(m)(m)(m)0.51%(m)(m)(m)(m)(m)(m)
2018-09-30Reported-$933,000.00(m)(m)(m)-11.35%(m)(m)$3.85M$525.00K$4.93M(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$11.97M(m)(m)(m)-17.98%$641.00K-$13.63M$27.78M$6.25M$46.62M$51.00K
2024-12-31Reported-$11.94M(m)(m)(m)-21.45%$515.00K-$13.28M$22.53M$5.38M$41.37M$12.00K
2023-12-31Reported-$20.64M(m)(m)(m)-39.27%$828.00K-$14.46M$23.09M$4.87M$47.43M$33.00K
2022-12-31Reported-$44.45M(m)(m)(m)-97.56%$4.32M-$32.14M$24.21M$9.88M$52.02M-$282.00K
2021-12-31Reported-$23.17M(m)(m)(m)-47.97%$2.37M-$20.27M$20.59M$7.24M$44.54M$175.00K
2020-12-31Reported-$14.69M(m)(m)(m)-34.99%$455.00K-$14.08M$16.56M$3.57M$37.03M-$79.00K
2019-12-31Reported-$8.7M(m)(m)(m)-21.54%$403.00K-$9.71M$18.81M$2.18M$28.70M$25.00K
2018-12-31Reported-$4.28M(m)(m)(m)-13.19%$199.00K-$9.30M$15.38M$2.13M$19.68M$58.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Freenome, Inc. (FRNM)United States$0.143B
BIODESIX INC (BDSX)United States$0.312B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45